<html><head><meta charset='utf-8'><style>body{font-family:Arial}table{border-collapse:collapse;width:100%;font-size:12px}th,td{border:1px solid #ddd;padding:6px 8px;text-align:left}th{background:#f5f5f5}</style></head><body>
<h3>Table 3. Top 20 differentially abundant pathways (case vs control, PD-only)</h3>
<table><thead><tr>
<th>Rank</th>
<th>Pathway_ID</th>
<th>Description</th>
<th>logFC</th>
<th>q</th>
<th>Direction</th>
<th>Mean_CPM_control</th>
<th>Mean_CPM_case</th>
</tr></thead><tbody>
<tr>
<td> 1</td>
<td>PANTO-PWY: phosphopantothenate biosynthesis I</td>
<td>PANTO-PWY: phosphopantothenate biosynthesis I</td>
<td>0.3877</td>
<td>3.21e-34</td>
<td>up case</td>
<td>357.8</td>
<td>345.8</td>
</tr>
<tr>
<td> 2</td>
<td>FASYN-INITIAL-PWY: superpathway of fatty acid biosynthesis initiation (E. coli)</td>
<td>FASYN-INITIAL-PWY: superpathway of fatty acid biosynthesis initiation (E. coli)</td>
<td>0.3181</td>
<td>5.16e-32</td>
<td>up case</td>
<td>456.0</td>
<td>427.4</td>
</tr>
<tr>
<td> 3</td>
<td>PWY-5973: cis-vaccenate biosynthesis</td>
<td>cis-vaccenate biosynthesis</td>
<td>0.4559</td>
<td>1.15e-30</td>
<td>up case</td>
<td>322.1</td>
<td>308.6</td>
</tr>
<tr>
<td> 4</td>
<td>PWY-6163: chorismate biosynthesis from 3-dehydroquinate</td>
<td>chorismate biosynthesis from 3-dehydroquinate</td>
<td>0.2837</td>
<td>6.80e-26</td>
<td>up case</td>
<td>512.2</td>
<td>501.0</td>
</tr>
<tr>
<td> 5</td>
<td>PANTOSYN-PWY: superpathway of coenzyme A biosynthesis I (bacteria)</td>
<td>PANTOSYN-PWY: superpathway of coenzyme A biosynthesis I (bacteria)</td>
<td>0.3049</td>
<td>4.41e-25</td>
<td>up case</td>
<td>349.1</td>
<td>338.1</td>
</tr>
<tr>
<td> 6</td>
<td>1CMET2-PWY: folate transformations III (E. coli)</td>
<td>1CMET2-PWY: folate transformations III (E. coli)</td>
<td>0.2126</td>
<td>4.41e-25</td>
<td>up case</td>
<td>465.4</td>
<td>467.3</td>
</tr>
<tr>
<td> 7</td>
<td>PWY-6700: queuosine biosynthesis I (de novo)</td>
<td>queuosine biosynthesis I (de novo)</td>
<td>0.3156</td>
<td>1.36e-23</td>
<td>up case</td>
<td>435.5</td>
<td>413.4</td>
</tr>
<tr>
<td> 8</td>
<td>PWY-7663: gondoate biosynthesis (anaerobic)</td>
<td>gondoate biosynthesis (anaerobic)</td>
<td>0.4090</td>
<td>4.73e-23</td>
<td>up case</td>
<td>294.9</td>
<td>288.2</td>
</tr>
<tr>
<td> 9</td>
<td>PWY-5695: inosine 5'-phosphate degradation</td>
<td>inosine 5'-phosphate degradation</td>
<td>0.2041</td>
<td>4.73e-23</td>
<td>up case</td>
<td>442.0</td>
<td>432.8</td>
</tr>
<tr>
<td>10</td>
<td>COMPLETE-ARO-PWY: superpathway of aromatic amino acid biosynthesis</td>
<td>COMPLETE-ARO-PWY: superpathway of aromatic amino acid biosynthesis</td>
<td>0.2374</td>
<td>5.53e-21</td>
<td>up case</td>
<td>470.5</td>
<td>465.5</td>
</tr>
<tr>
<td>11</td>
<td>PWY0-1319: CDP-diacylglycerol biosynthesis II</td>
<td>PWY0-1319: CDP-diacylglycerol biosynthesis II</td>
<td>0.2668</td>
<td>3.66e-20</td>
<td>up case</td>
<td>424.9</td>
<td>402.9</td>
</tr>
<tr>
<td>12</td>
<td>PWY-5667: CDP-diacylglycerol biosynthesis I</td>
<td>CDP-diacylglycerol biosynthesis I</td>
<td>0.2667</td>
<td>3.66e-20</td>
<td>up case</td>
<td>424.9</td>
<td>402.9</td>
</tr>
<tr>
<td>13</td>
<td>ARO-PWY: chorismate biosynthesis I</td>
<td>ARO-PWY: chorismate biosynthesis I</td>
<td>0.2251</td>
<td>9.90e-18</td>
<td>up case</td>
<td>494.6</td>
<td>489.3</td>
</tr>
<tr>
<td>14</td>
<td>PWY-6737: starch degradation V</td>
<td>starch degradation V</td>
<td>0.2655</td>
<td>1.04e-17</td>
<td>up case</td>
<td>650.5</td>
<td>622.1</td>
</tr>
<tr>
<td>15</td>
<td>RIBOSYN2-PWY: flavin biosynthesis I (bacteria and plants)</td>
<td>RIBOSYN2-PWY: flavin biosynthesis I (bacteria and plants)</td>
<td>0.3088</td>
<td>1.31e-16</td>
<td>up case</td>
<td>331.5</td>
<td>306.7</td>
</tr>
<tr>
<td>16</td>
<td>DTDPRHAMSYN-PWY: dTDP-&amp;beta;-L-rhamnose biosynthesis</td>
<td>DTDPRHAMSYN-PWY: dTDP-&amp;beta;-L-rhamnose biosynthesis</td>
<td>0.2237</td>
<td>1.84e-15</td>
<td>up case</td>
<td>600.2</td>
<td>593.0</td>
</tr>
<tr>
<td>17</td>
<td>PWY-7199: pyrimidine deoxyribonucleosides salvage</td>
<td>pyrimidine deoxyribonucleosides salvage</td>
<td>0.2206</td>
<td>3.55e-14</td>
<td>up case</td>
<td>348.4</td>
<td>331.7</td>
</tr>
<tr>
<td>18</td>
<td>PYRIDNUCSYN-PWY: NAD de novo biosynthesis I (from aspartate)</td>
<td>PYRIDNUCSYN-PWY: NAD de novo biosynthesis I (from aspartate)</td>
<td>0.1771</td>
<td>6.05e-14</td>
<td>up case</td>
<td>322.2</td>
<td>322.8</td>
</tr>
<tr>
<td>19</td>
<td>PWY-6385: peptidoglycan biosynthesis III (mycobacteria)</td>
<td>peptidoglycan biosynthesis III (mycobacteria)</td>
<td>0.1648</td>
<td>3.69e-12</td>
<td>up case</td>
<td>520.4</td>
<td>519.8</td>
</tr>
<tr>
<td>20</td>
<td>PWY-6897: thiamine diphosphate salvage II</td>
<td>thiamine diphosphate salvage II</td>
<td>0.2469</td>
<td>2.11e-11</td>
<td>up case</td>
<td>262.7</td>
<td>251.5</td>
</tr>
</tbody>
<tfoot><tr><td colspan='100%'><ul>
<li>Benjamini-Hochberg FDR; pathways tested: 510.</li>
<li>Covariates: Age_at_collection, Sex, BMI, Laxatives, collection_method.</li>
<li>Sign: positive log2FC = higher in case (constipated PD).</li>
<li>Pathway table derived from published HUMAnN outputs (not re-run).</li>
</ul></td></tr></tfoot>
</table></body></html>
